Latest week
10 Jul 2026
Close
33.549999
Fair value
57.202917
Next-week expectancy
Negative 44.64%
Sharemaestro

ALVO-SDB Chart Pack

Alvotech SDB

Exchange
STO
Latest week
10 Jul 2026
Close
33.549999
Fair value
57.202917
Next-week expectancy
Negative 44.64%
Generated
17 Jul 2026 09:38
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, ALVO-SDB rose 3.23%, moving from 32.50 to 33.55. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -42.63 and has remained broadly mixed across the 12-week window. Market Dynamics is 1.12 on the latest week. Next-week expectancy is negative at 44.64% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
33.55
12-Week Change
3.23%
Trend Signal
Inactive
Next-Week Expectancy
Negative 44.64%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-42.63
Market Dynamics
1.12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
33.55
12-Week Change
3.23%
Trend Signal
Inactive
Next-Week Expectancy
Negative 44.64%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-42.63
Market Dynamics
1.12

Over the latest 12 completed weeks ending 2026-07-10, ALVO-SDB rose 3.23%, moving from 32.50 to 33.55. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -42.63 and has remained broadly mixed across the 12-week window. Market Dynamics is 1.12 on the latest week. Next-week expectancy is negative at 44.64% based on similar historical setup states.

Industry Peers

Sweden equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
NEWBRY Newbury Pharmaceuticals AB (publ) STO 10 Jul 2026 2.06 2.50 1.22 2.42 17.48%
ENZY Enzymatica AB (publ) STO 10 Jul 2026 2.27 2.60 2.21 2.48 9.25%
CINPHA Cinclus Pharma Holding AB (publ) STO 10 Jul 2026 11.28 12.20 11.18 11.98 6.21%
NANEXA Nanexa AB (publ) STO 10 Jul 2026 3.57 3.73 3.53 3.70 3.64%
ACUC AcuCort AB STO 10 Jul 2026 0.62 0.67 0.60 0.64 3.23%
MOB Moberg Pharma AB (publ) STO 10 Jul 2026 9.45 9.73 9.23 9.47 0.21%
PMED PEPTONIC Medical AB STO 10 Jul 2026 0.00 0.00 0.00 0.00 0.00%
VIVE Vivesto AB STO 10 Jul 2026 8.50 9.18 8.10 8.45 -0.59%
EQL EQL Pharma AB STO 10 Jul 2026 23.60 24.30 22.30 23.35 -1.06%
SOBI Swedish Orphan Biovitrum AB (publ) STO 10 Jul 2026 480.00 487.00 470.60 471.20 -1.83%
KLAR Klaria Pharma Holding AB (publ.) STO 10 Jul 2026 0.78 0.85 0.74 0.76 -2.31%
BIOG-B BioGaia AB (publ) STO 10 Jul 2026 120.20 121.50 116.50 116.50 -3.08%
ORX Orexo AB (publ) STO 10 Jul 2026 24.40 25.35 22.50 23.20 -4.92%
CRNO-B Cereno Scientific AB (publ) STO 10 Jul 2026 5.13 5.21 4.70 4.83 -5.93%
DICOT Dicot Pharma AB STO 10 Jul 2026 0.21 0.21 0.18 0.19 -7.16%
ODI ODI Pharma AB STO 10 Jul 2026 2.56 3.00 2.12 2.30 -10.16%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.